Nan Fung Trinity HK Ltd. Makes New $23.21 Million Investment in GE HealthCare Technologies Inc. $GEHC

Nan Fung Trinity HK Ltd. purchased a new position in GE HealthCare Technologies Inc. (NASDAQ:GEHC) in the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund purchased 309,000 shares of the company’s stock, valued at approximately $23,206,000. GE HealthCare Technologies comprises about 2.3% of Nan Fung Trinity HK Ltd.’s holdings, making the stock its 14th largest holding. Nan Fung Trinity HK Ltd. owned approximately 0.07% of GE HealthCare Technologies as of its most recent SEC filing.

Other hedge funds have also made changes to their positions in the company. Allianz SE lifted its holdings in GE HealthCare Technologies by 165.2% in the 2nd quarter. Allianz SE now owns 350 shares of the company’s stock worth $26,000 after purchasing an additional 218 shares during the last quarter. E Fund Management Hong Kong Co. Ltd. raised its position in shares of GE HealthCare Technologies by 130.7% in the third quarter. E Fund Management Hong Kong Co. Ltd. now owns 346 shares of the company’s stock valued at $26,000 after purchasing an additional 196 shares during the period. Godsey & Gibb Inc. acquired a new stake in shares of GE HealthCare Technologies in the third quarter worth $26,000. Gladwyn Financial Advisors Inc. bought a new stake in shares of GE HealthCare Technologies during the 2nd quarter worth $34,000. Finally, Piscataqua Savings Bank grew its stake in GE HealthCare Technologies by 173.4% in the 3rd quarter. Piscataqua Savings Bank now owns 473 shares of the company’s stock valued at $36,000 after buying an additional 300 shares during the last quarter. Institutional investors and hedge funds own 82.06% of the company’s stock.

Analysts Set New Price Targets

GEHC has been the subject of a number of research analyst reports. BTIG Research reissued a “buy” rating and set a $87.00 target price on shares of GE HealthCare Technologies in a research report on Friday, November 21st. Weiss Ratings reissued a “hold (c+)” rating on shares of GE HealthCare Technologies in a research report on Monday, December 29th. Wells Fargo & Company dropped their price target on GE HealthCare Technologies from $89.00 to $87.00 and set an “overweight” rating on the stock in a research report on Thursday, October 30th. Barclays assumed coverage on GE HealthCare Technologies in a report on Monday, October 13th. They set an “equal weight” rating and a $86.00 price target for the company. Finally, Jefferies Financial Group raised their price objective on shares of GE HealthCare Technologies from $95.00 to $105.00 and gave the stock a “buy” rating in a research note on Thursday, December 11th. Seven analysts have rated the stock with a Buy rating, six have given a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat, GE HealthCare Technologies currently has a consensus rating of “Hold” and a consensus target price of $90.33.

GE HealthCare Technologies Trading Up 0.2%

GE HealthCare Technologies stock opened at $78.97 on Friday. GE HealthCare Technologies Inc. has a 12 month low of $57.65 and a 12 month high of $94.80. The stock has a market cap of $35.97 billion, a price-to-earnings ratio of 16.32, a price-to-earnings-growth ratio of 2.38 and a beta of 1.08. The business has a 50 day moving average price of $82.63 and a two-hundred day moving average price of $77.35. The company has a quick ratio of 0.95, a current ratio of 1.18 and a debt-to-equity ratio of 0.83.

GE HealthCare Technologies (NASDAQ:GEHC) last issued its earnings results on Wednesday, October 29th. The company reported $1.07 EPS for the quarter, beating analysts’ consensus estimates of $1.05 by $0.02. The business had revenue of $5.14 billion during the quarter, compared to analyst estimates of $5.07 billion. GE HealthCare Technologies had a return on equity of 22.52% and a net margin of 10.94%.GE HealthCare Technologies’s revenue was up 5.8% on a year-over-year basis. During the same period in the prior year, the company posted $1.14 earnings per share. As a group, equities analysts forecast that GE HealthCare Technologies Inc. will post 4.68 EPS for the current year.

GE HealthCare Technologies Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Friday, February 13th. Stockholders of record on Friday, January 9th will be given a dividend of $0.035 per share. This represents a $0.14 annualized dividend and a dividend yield of 0.2%. The ex-dividend date is Friday, January 9th. GE HealthCare Technologies’s payout ratio is 2.89%.

About GE HealthCare Technologies

GE HealthCare Technologies (NASDAQ: GEHC) is a global medical technology and diagnostics company that develops, manufactures and markets a broad range of products and services for healthcare providers. Its portfolio centers on diagnostic imaging systems, including MRI, CT, PET and X-ray modalities, as well as ultrasound equipment. The company also supplies patient monitoring and anesthesia delivery systems, interventional and surgical imaging solutions, and molecular imaging technologies used in both clinical care and research settings.

In addition to hardware, GE HealthCare offers software, analytics and lifecycle services aimed at improving clinical workflows and equipment uptime.